Keyphrases
Cutaneous T-cell Lymphoma
100%
Total Skin Electron Beam Therapy (TSEBT)
33%
Malignant T Cells
28%
Mycosis Fungoides
26%
Notch1
25%
Notch Signaling
22%
Staphylococcus Aureus
21%
Induced Apoptosis
20%
Staphylococcal Enterotoxins
13%
Chemotherapy-induced
11%
Nonmalignant
11%
Stage IB
10%
Patient-derived
10%
Endolysin
9%
Skin Colonization
9%
Lymphoma Cells
9%
T Cells
8%
Overall Response Rate
8%
MDM2 Inhibitor
8%
Skin Barrier Dysfunction
8%
Filaggrin
8%
CD30+ Lymphoproliferative Disorders
8%
JAK-STAT Pathway
8%
Putative Drug Targets
8%
Stimulator of Interferon Genes Pathways
8%
Prospective Phase II Study
8%
Validation Studies
8%
Interferon-α (IFN-α)
8%
AKT Pathway
8%
DNA Damage
8%
Pooled Analysis
8%
Senescence
8%
Debulking
8%
Photochemotherapy
8%
Eczema
8%
Transcriptional Repressor
8%
Signal Transducer
8%
Chemotherapeutic Treatment
8%
Keratinocytes
8%
New Therapeutic Approaches
8%
Interferon lambda (IFN-λ)
8%
Moderate to Severe
8%
T Cell Proliferation
8%
MicroRNA-155 (miR-155)
8%
Population-based Cohort Study
8%
Atopic Dermatitis
8%
National Cohort Study
8%
Nutlin-3
8%
Malignant Lymphoma
8%
Psoriasis
8%
Medicine and Dentistry
Cutaneous T Cell Lymphoma
65%
Total Skin Electron Therapy
25%
Low Drug Dose
25%
Notch Signaling
24%
Mycosis fungoides
23%
Notch
15%
Programmed Cell Death
15%
T Cell
12%
Anaplastic Large Cell Lymphoma
10%
Lymphoma
9%
Cytokine
9%
Chemotherapy
8%
Psoriasis
8%
Filaggrin
8%
JAK-STAT Signaling
8%
Lymphoproliferative Disease
8%
Cohort Analysis
8%
Debulking
8%
Interferon Type III
8%
Photochemotherapy
8%
Staphylococcus Aureus
8%
Interferon
8%
microRNA 155
8%
Nutlin 3
8%
Protein P53
8%
Clinical Study
8%
Peripheral T-Cell Lymphoma
8%
Lymphoma Cell
6%
Disease
6%
Small Interfering RNA
6%
Skin Defect
5%
Staphylococcus Enterotoxin
5%
Etoposide
5%
Gemcitabine
5%
Doxorubicin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cutaneous T Cell Lymphoma
58%
Chemotherapy
16%
Protein P53
16%
Mycosis fungoides
14%
Disease
12%
Syndrome
11%
Cytokine
8%
Filaggrin
8%
Clinical Study
8%
Anaplastic Large Cell Lymphoma
8%
Peripheral T Cell Lymphoma
8%
Cohort Study
8%
microRNA 155
8%
Staphylococcus Aureus
8%
Nutlin 3
8%
microRNA 122
8%
Staphylococcus Enterotoxin
5%
